Combining ALDH1B1 inhibition with other therapies, such as chemotherapy, targeted therapies, or immunotherapies, could offer more effective strategies for lung adenocarcinoma in the future; however, these strategies require further exploration. Here, ALDH1B1 is linked to lung adenocarcinoma.